Abstract:Objective To study the role of endothlin-1(ET-1),nitric oxide(NO),thromboxane A2(TXA2),prostacyclin(PGI2),5-hydroxytryptamine(5-HT) and transforming growth factor-β1(TGF-β1) on pathogenesis of PPHTN.Methods A case-control study of 6 vasoactive substances in 4 PPHTN patients(P group) and 12 PHT patients(C group) was conducted,and another 10 patients with gastroenteric carcinoma were set as normal control group(N group).Blood samples from femoral vein,main pulmonary artery and radial collateral artery of each patient studied were collected.Serum concentrations of ET-1,TXB2,5-HT and TGF-β1 were measured using an enzyme linked immunoassay;serum concentration of NO was measured by the method of nitric acid reductase;plasma level of PGF1α was measured with radioimmunoassay.The results of 3 groups were compared and analyzed.Results The ET-1 levels in P group and C group were significantly above normal range.ET-1 concentrations in pulmonary and systemic circulation of C group was about 2.8 times as high as N group,while those of P group were about 4 times as high as N group,and there was statistical significance between P group and C group,especially in pulmonary artery [(270.62±9.03)pg/mL vs(191.56±40.90)pg/mL;t=3.752,P=0.002].The concentrations of NO [femoral vein: P group=(47.49±11.05)μmol/L,C group= 58.83±39.85)μmol/L,N group=(23.07±7.64)μmol/L;pulmonary artery: P group=(49.99±11.79)μmol/L,C group=(59.76±43.63)μmol/L,N group=(23.33±8.02)μmol/L;radial collateral artery: P group=(43.56±9.99)μmol/L,C group=(56.84±36.38)μmol/L;N group=(22.30±6.90)μmol/L] and PGF1α [femoral vein: P group=(439.28±174.58)pg/mL,C group=(423.29±289.63)pg/mL,N group=(83.98±11.94)pg/mL;pulmonary artery: P group=(428.94±145.13)pg/mL,C group=(378.43±214.31)pg/mL,N group=(76.47±11.91)pg/mL;radial collateral artery: P group=(384.42±158.40)pg/mL,C group=(383.65±276.62)pg/mL;N group=(78.27±10.86)pg/mL] in P group and C group were significantly higher than those in N group,but had no difference between P group and C group.The concentration of TXB2 in radial collateral artery of P group was highly above normal range and was significantly higher than that in C group [(111.02±52.58)pg/mL vs(41.59±13.25)pg/mL,t=2.322,P=0.036].The 5-HT level in femoral vein of P group was in normal range and the levels in main pulmonary artery and radial collateral artery were significantly higher than those of N group as well as had statistical significance with those of C group(t=10.04,P0.01;t=6.994,P0.01).TGF-β1 had a normal test results in all groups.Conclusion The extremely elevated ET-1 level and imbalance between ET-1 and NO probably play a key role in the pathogenesis of PPHTN.PGI2 and TXA2 are not the launching factors of PPHTN,but TXA2 may worsen pulmonary hypertension of PPHTN.Overproduction of 5-HT in alimentary tract,which causes elevation of 5-HT level in pulmonary artery and radial collateral artery,may be another important cause of PPHTN.

The role of Angiopoietin-1 in pulmonary disease

Endothelial Progenitor Cells May Inhibit Apoptosis of Pulmonary Microvascular Endothelial Cells: New Insights into Cell Therapy for Pulmonary Arterial Hypertension

[Advances in the Research of Mechanisms of Promotion of Vascularization by Angiogenin and Its Application].

Role of angiogenin-like proteins in tumorigenesis and development

Progress in Relationship between PAI-1 and Lung Injury

Cartilage Oligomeric Matrix Protein-Angiopoietin-1 Has a Protective Effect of Vascular Endothelial Barrier in Rat with Acute Necrotizing Pancreatitis

Data from Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment

Effect of AngII and TGF-β1 on cigarette smoke-induced pulmonary arterioles remodeling

Role of Platelet in Angiogenesis

Vascular Endothelial Growth Factor 165 and Angiopoietin-1 Protected Myocardium Through Phosphatidy Linositol-3 Kinase and Bcl-2 Signaling Pathways

Development about Effects and Mechanisms of PAI-1 in Tumor Angiogenesis

ASSA13-03-41 Angiotensin II Inhibits Cardiac Angiogenesis Via the Cooperation of P53 and Jagged 1

Role of Vasoactive Substances in Pathogenesis of Portopulmonary Hypertension

Nanoparticle Delivery of Angiogenic Gene Therapy. Save the Vessels, Save the Lung!

A20 Deficiency Leads to Angiogenesis of Pulmonary Artery Endothelial Cells Through Stronger NF‐κB Activation under Hypoxia

Angiotensin signalling in pulmonary fibrosis

The Role of Vascular Endothelial Growth Factor in Small-airway Remodelling in a Rat Model of Chronic Obstructive Pulmonary Disease

DOT1L Promotes Angiogenesis Through Cooperative Regulation of VEGFR2 with ETS-1

VEGF165 and angiopoietin-1 synergistically improve cardiac function of the infarct rats

Vascular endothelial growth factor and angiopoietin-1 protected cardiac myoblasts from apoptosis induced by H2O2

Gene Expression of MMP-1 of Pulmonary Vascular Remodeling in Rats with Pulmonary Hypertension